secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bicara Therapeutics Inc. (BCAX)
CIK:        0002023658
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0002023658-25-000063
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bicara Therapeutics subleases 9,682 sq ft of HQ office space through June 2027
------------------------------------------------------------------------------

- Sublease covers approx. 9,682 sq ft at 116 Huntington Ave, Boston, MA.
- Base rent: $532,510/yr (Year 1), $543,160.20 (Year 2), $554,023.40 (Year 3).
- Sublease term ends June 30, 2027; security deposit of $45,263.35 required.
- Effective upon consent of Columbia Reit – 116 Huntington, LLC received June 4, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2023658/000202365825000063/0002023658-25-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2023658/000202365825000063/bcax-20250602.htm
  HTML page:      https://secwatch.observer/filing/0002023658-25-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer